The Chair’s action-learning approach is based on real-world case studies, role playing and negotiation workshops co-facilitated by the decision-makers actually involved in the case studies. We also organize immersion visits to world-class medical centers that use cutting-edge innovations and implement value-based health care initiatives. In essence, the Chair curriculum focuses on fostering leadership and decision-making skills, promoting team spirit, and providing international exposure.The Chair’s action-learning approach works as a maturity incubator for students. It provides a source of energy and inspiration. Our goal is to kindle flames - not fill vessels.
This course provides participants with the practical skills needed to harness and manage technical and organizational innovations. Case studies are analyzed in a wide variety of fields: intellectual property, investment funds, VBHC strategy for providers and insurers, precision medicine, gene editing, vaccine market, artificial intelligence, surgical robotics, and more. Role playing and negotiation workshops are conducted with experts and the decision-makers actually involved in the cases discussed. By meeting with industry leaders, participants can establish contacts with enterprises and develop career opportunities. The international scope of the seminar allows students to approach these complex challenges from a global perspective.
In this course, participants analyze and help resolve tensions and ethical issues inherent in the health care industry. Participants are confronted with critical situations presented in a number of case studies from a dozen different countries. Through negotiation workshops and role playing, they explore a wide variety of pragmatic solutions designed to defuse tensions and convert technological and organizational innovations into societal progress. Topics include crisis management during a pandemic alert, blockbuster drug recalls, development of stem cell biobanks, commercialization of expensive drugs for rare conditions, launching of clinical trials in developing countries, etc. The topics fuel discussions on performance vs. risk and pragmatism vs. exemplarity. Role playing and negotiation workshops reveal each participant’s set of values and allow them to develop leadership skills.
As lead authors, our team publishes scientific articles in academic journals such as PLOS, J of Bone & Joint Surgery, Yale J of Health Policy. Recent publications in health economics and health policy focused on innovations in the life sciences, and more specifically on companion diagnostics, gene editing (CRISPR), and cord blood stem cell biobanks. Today, our core research focuses on value-based health care. We developed a PROM instrument in orthopedics (Q-PASREL) that measures the quality of the patient-surgeon relationship and its impact on return to work. Another research project on cataract surgery (PROMCAT) evaluates how public reporting of patient outcomes impacts medical practices and health systems. We also survey patients in 4 EU countries to determine what quality indicators matter most when choosing or evaluating a medical team. The Chair contributes to a report commissioned by EIT Health – a body of the European Union – entitled Implementing Value-Based Health Care in Europe: Handbook for Pioneers. The report aims to draw practical lessons from leading European medical centers involved in VBHC across 22 EU countries. The objective is to share tools and best practices – a user guide for implementation – in order to accelerate the development of outcome-based quality registries to enable medical teams to evaluate, improve and incentivize their results.
Chair of Innovation & Value in Health, University of Paris School of Medicine
A professor at the University of Paris School of Medicine, Gregory Katz holds the Chair of Innovation & Value in Health. His research activities focus on patient-reported outcomes and the impact of transparent benchmarks on clinical practices. He is the Academic Director of the European Union report entitled Implementing Value-Based Health Care in Europe: Handbook for Pioneers (2020). Between 2006 and 2019, Katz was the Director of research and innovation in two leading private hospital groups in Europe. He is the Founder of the VBHC Consortium, a nonprofit dedicated to accelerating the emergence of Value-Based Health Care (VBHC) to enable medical teams to compare and improve patient outcomes. Since 2020, he is also President of PromTime, a company specialized in implementing outcome-driven ecosystems. From 2003-2005, Katz was a Visiting Professor at INSEAD (Singapore). From 2004 to 2015, he was a Professor at ESSEC Business School (Paris-Singapore), Chair of Therapeutic Innovation, and Co-director of the Institute for Health Economics & Management. His pro bono activities include Vice-President of the Eurocord (2004-2008), a nonprofit conducting clinical research on cord blood transplantation across 56 countries. He was Chairman of the Scientific Board of the GlaxoSmithKline Vaccines Global Innovation Fund (2012-2015), Chairman of the think tank Digital Leaders in Health (2018), and Senior fellow of the U.S. Center for Medicine in the Public Interest. Since 2020, Katz is an elected member of the French National Academy of Surgery. He is the recipient of several awards, including the San Benedetto International Prize for his achievements in bioethics and humanism (2009), the Special Jury Award from the French Fédération de l’Hospitalisation Privée (2012), and was guest of honor of the Grand Rounds Lecture at the UCLA Fielding School of Public Health (2015). In 2020, the French Ministry of Health and the national payer - the Assurance Maladie - commissioned Prof. Katz and his team to implement the first VBHC experiment on cataracts to incentivize practitioners on patient outcomes.
President of the Center for Medicine in the Public Interest
Visiting Professor
Peter Pitts is President of the Center for Medicine in the Public Interest. He is a former member of the United States Senior Executive Service and Associate Commissioner of the US Food & Drug Administration. Pitts is a member of the Council for International Organizations of Medical Sciences (CIOMS is a NGO established jointly by WHO and UNESCO in 1949) Expert Working Group to help advance patient involvement in the development and safe use of medicines. He is the lead author of many peer reviewed publications including the Lancet and Nature Biotechnology. He is an Associate Editor of Therapeutic Innovation & Regulatory Science (official DIA journal), a member of the External Advisory Board, IMS Institute for Healthcare Informatics in Asia, Executive Advisory Board, the Galien Foundation, Editorial Advisory Board, Food and Drug Policy Forum, Advisory Board, Journal of Commercial Biotechnology and the Editorial Advisory Board, The Patient Magazine. Pitts lives in New York City.
MSc in Health Economics
Program Manager
PhD in Health Economics
Senior Research and Teaching Fellow
MSc in International Management, MD student
Research fellow
The Chair actively participates in the organization of a series of conferences on value-based health care with experts from around the world. We invite health system leaders to share their experience in how VBHC is transforming practices and informing payment models and policy reforms. Recent conferences were organized in partnership with the International Consortium for Health Outcomes Measurement (ICHOM), with the participation of Professor Michael Porter (Harvard Business School). The Chair also contributes to other VBHC conferences organized by the think tank Digital Leaders in Health, and to the Summit organized by EIT Health.
CONFERENCES
Shifting to Value-Based Health Care, Conseil Economique, Social et Environnemental, May 18, 2018
Value-Based Health Care in the Digital Era, Institut Imagine, Decembre 18, 2018
EIT Health Summit, Palais Brongniart, December 2-3, 2019
The Chair welcomes students from all over the world from many backgrounds (PhD, MD, PharmD, MSc), and in particular university exchange students. Our program is geared to passionate, hard-working and dedicated students, the kind that “wake up at 3:00 am with an idea”, the multi-taskers, the builders of tomorrow’s health care systems, the ones we are proud of.
The Chair is a springboard for careers in life science companies. Positions include medical affairs, R&D, public affairs, global marketing, and business development. Chair graduates also become hospital managers, or join consulting firms, investment funds, patient advocacy groups, health authorities… or start their own company.
Only students from University of Paris School of Medicine are eligible to apply. The Chair welcomes medical students (years 4, 5, 6 and residents), PharmD and PhD students, master students, and students from university exchange programs (Erasmus, etc.). The application process involves the following steps:
Amgen & Air Liquide are supporting the Chair through unrestricted grants that do not interfere with the Chair’s teaching and scientific activities. The Chair remains academically independent in terms of orientations, organization & publications.
benjamin.gibrat@u-paris.fr
+33 6 77 45 27 77
University of Paris School of Medicine
Chair of Innovation & Value in Health
160 rue de Vaugirard 7015 Paris, France